Bayer said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma treatment in the company's biggest deal in years.

拜耳表示，已同意以最高24.5亿美元的价格收购珀弗斯治疗公司，这家专注于眼科的制药公司正在开发一种潜在的治疗青光眼的药物。这笔交易是拜耳多年来最大的一笔收购。



The German pharmaceutical-and-agricultural group said Wednesday that the acquisition of San Francisco-based Perfuse would complement its drug vpn软件免费 pipeline and vpn免费 leverage its ophthalmology footprint. Eye drug 免费vpn Eylea was the top-selling vpn免费 product at Bayer's pharma business last year, but the medicine is now facing vpn免费 pricing pressures vpn软件免费 after it 免费vpn went vpn免费下载 off patent.

这家德国制药与农业集团周三表示，收购总部位于旧金山的珀弗斯将补充其药物研发管线，并利用其在眼科领域的既有布局。 眼科药物艾力雅（Eylea）是拜耳制药业务去年最畅销的产品，但该药物专利到期后，正面临定价压力。

Perfuse's lead drug candidate is an experimental treatment for glaucoma and diabetic retinopathy currently being tested in mid-stage clinical 免费vpn trials, Bayer said. It has the potential to become one of the first disease-modifying vpn免费下载 treatments for both conditions, the company added.

拜耳表示，珀弗斯的主要候选药物是一种用于治疗青光眼和糖尿病视网膜病变的实验性疗法，目前正处于中期临床试验阶段。 拜耳补充称，该药物有潜力成为针对这两种疾病的首批改善病程的治疗方法之一。

Bayer said it would pay $300 million upfront, with the rest of the price subject to hitting development, regulatory, and commercial targets.

拜耳表示将先期支付3亿美元，其余款项将取决于后续研发、监管及商业目标的达成情况。

Perfuse is Bayer's biggest acquisition since its takeover of AskBio for up to vpn免费下载 $4 billion in 2020, a company spokeswoman said.

拜耳公司的一位发言人表示，此次收购珀弗斯是拜耳自2020年以最高40亿美元收购AskBio以来最大的一笔交易。

Big pharma companies often buy smaller drugmakers to complement the work of their own labs, fill their pipelines and make up for medicines losing patent protection. But Bayer's efforts to bring down debt meant it largely sat out recent vpn软件免费 industry dealmaking even as its biggest medicines—heart drug Xarelto vpn免费 and Eylea—went off patent.

大型制药公司通常通过收购小型药企来补充自身实验室的研发工作、充实药物管线，并弥补因专利到期而受到影响的药物。 但拜耳为降低债务所做的努力意味着，它在近期行业交易中基本处于旁观状态，即便其最重要的两款药物——心脏药物拜瑞妥（Xarelto）和眼药艾力雅（Eylea）——已失去专利保护。

Bayer's $63 billion acquisition of vpn软件免费 Monsanto in 2018 saddled 免费vpn it with debt and litigation and the group has focused on cutting costs and streamlining operations in recent years.

拜耳在2018年以630亿美元收购孟山都（Monsanto），使其背负了巨额债务和诉讼。近年来，该集团一直专注于削减成本和精简运营。

After the AskBio acquisition, Bayer bought Vividion Therapeutics for up to $2 billion and KaNDy Therapeutics for up to $875 million, but its dealmaking activity most recently centered on early-stage drug candidates that had yet to be tested in humans.

在收购AskBio之后，拜耳又以最高20亿美元收购了Vividion Therapeutics，并以最高8.75亿美元收购了KaNDy Therapeutics。但其近期的交易活动主要集中在尚未进行人体试验的早期候选药物上。

Bayer's pharma head, Stefan Oelrich, last month said in an interview with The Wall Street Journal that the company was in negotiations vpn免费下载 for a number of deals.

拜耳制药业务负责人斯特凡·奥尔里希上个月在接受《华尔街日报》采访时表示，公司正在就多项交易进行谈判。

素材来源：iYuba

本文来自公众微信号：英语阅读EnglishDaily